During the past decade, Hospital do Cancer III conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital do Cancer III" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Cancer Research UK Cambridge Institute" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hospital do Cancer III" are "Breast Cancer" (2 trials), "Breast Neoplasm" (1 trials), "Medullary Thyroid Cancer" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Solid Tumors Harboring NTRK Fusion" (1 trials). Many other conditions were trialed in "Hospital do Cancer III" in a lesser frequency.

Most popular intervention types in "Hospital do Cancer III" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Selpercatinib" (2 trials), "Anastrozole 1Mg Tablet" (1 trials), "BAY2757556 (Larotrectinib, Vitrakvi)" (1 trials), "Cabozantinib" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital do Cancer III" are 3 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital do Cancer III". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hospital do Cancer III, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital do Cancer III, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".